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Abstract
Background: External radiation therapy (RT) has been available for small animals in Sweden since
2006. This study was designed to obtain information on owner experiences and perceptions related
to RT of cancer in their dogs. Another survey was used to determine the attitudes about use of
RT in a group of Swedish veterinarians. Their responses were analyzed and compared to their level
of knowledge of oncology and RT.
Methods: Owners of all dogs (n = 23) who had undergone RT for malignancy at Jönköping Small
Animal Hospital between March 2006 to September 2007 were interviewed. A questionnaire was
given to a selected group of veterinarians.
Results: All 23 owners responded. All owners thought that their dog did well during RT and most
that their dog was also fine during the following phase when acute RT-related skin reactions occur
and heal. Three owners stated that their dog had pain that negatively impacted quality of life
because of radiation dermatitis. Five owners reported that RT positively impacted quality of life of
the dog during the first weeks after RT because palliation was achieved. The owners were not
disturbed by the efforts required of them. All but one owner (22 of 23) stated that they would make
the same decision about RT again if a similar situation occurred. The most important factor for this
decision was the chance to delay occurrence of tumour-related discomfort. The chance for cure
was of less importance but still essential, followed by expected side effects. Time commitments,
travel, number of treatments required and financial cost; all had low impact. The veterinarian survey
showed that less background knowledge of small animal oncology/RT was associated with more
negative expectations of RT for small animals.
Conclusion: The results show that for these owners, RT was a worthwhile treatment modality
and that the discomfort for the dog was manageable and acceptable relative to the benefits.
Improved continuing education about small animal RT in Sweden will likely result in increased
evidence-based and positive treatment recommendations concerning RT by veterinarians.
Background
Treatment with external beam radiation is one of the cor-
nerstones in human cancer therapy. Among dogs, cancer
was the most common specific cause of death or euthana-
sia as registered by a Swedish animal insurance company.
Of all deaths with a diagnosis, 18% had cancer [1]. In vet-
erinary medicine, radiation therapy (RT) has been used
for the past 70 years and the science of RT is continuously
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developing [2-4]. The availability is still not worldwide
but has increased in several industrialized countries. There
were over 60 veterinary RT facilities in North America in
December 2007 according to the Veterinary Cancer Soci-
ety's homepage [5]. In Europe this number was only 8
(personal communication, Prof. Dr med vet B Kaser-Hotz,
Diplomate ACVR, ECVDI Animal Oncolocy and Imaging
Center Hünenberg, Schwitzerland). Thus RT, together
with chemotherapy, are, in many countries, well accepted
and commonly used treatment modalities for cancer in
pets. In Scandinavia although surgery for cancer is well
established, external RT has not been accessible and
chemotherapy (except for the use of mitotane) has been
regularly utilized in only a limited numbers of clinics and
mainly during the last decade (Personal communication,
Oncology Professor AT Kristensen, Faculty of Life sciences
University of Copenhagen and Dr V Kristiansen, Norwe-
gian school of Veterinary Sciences, Oslo). Systemic RT
using radio-iodine has been available in Sweden for the
treatment of hyperthyroid cats [6].
In February 2006, an orthovoltage machine was installed
at one animal hospital in the south of Sweden (Jönköping
Small Animal Hospital). This machine is dedicated to
treat small animals with external beam RT. During the ini-
tial stages of offering a novel treatment modality, it is
unlikely that veterinarians and owners will be fully aware
of the limits and benefits of the new technique. With
respect to cancer there are emotional factors that influence
treatment decisions, in addition to the medical facts,
among both owners and many veterinarians. It was there-
fore deemed worthwhile to document perceptions of
owners and veterinarians on RT at the start of its introduc-
tion in Sweden.
Owner satisfaction with therapy has been studied for sev-
eral disease complexes [7-10]. With respect to cancer, data
on owner satisfaction with limb amputation has been
reported [11]. Perceptions about chemotherapy have
been studied in dog and cat owners [12]. In both studies
it was shown that most owners were content with the cho-
sen treatment for their animal.
The primary aim of this study was to obtain information
on experiences and perceptions of owners that chose to
have their dog undergo RT for cancer. The secondary aim
was to describe attitudes about RT in a group of Swedish
veterinarians, taking into account their level of knowledge
of this modality and related issues.
Materials and methods
Animals
All dogs that received RT for malignancy (n = 23) from
March 2006 to September 2007 were included
Radiation therapy protocol
To achieve full immobilization during RT, dogs were
sedated with a combination of medetomidine and butor-
phanol at the lowest effective dose. After RT, sedation was
antagonized by atipamezol. In a few instances, for exam-
ple, when the dog was experiencing temporary gastroin-
testinal disturbances, another form of anesthesia was
used, i.e. a combination of acepromacine, buprenorphine
and propofol.
The RT was administered using a Siemens Stabilipan orto-
voltage teletherapy unit, operated at 20 mA and 190 kV,
145 kV and 110 kV, filtered with 0.5 mm Cu, 4 mm Al and
1 mm Al respectively. Focal spot to skin distance was 50
or 60 cm depending on required depth dose. Radiother-
apy planning was by manual methods using single enface
or parallel-opposed fields. Radiotherapy field sizes (side
of square field) varied from 2 to 22 cm. Blocking in the
field by lead rubber (4 mm lead rubber = 2 mm Pb) or
lead eye lenses (2–3 mm Pb) were used in some cases. The
stated doses are mid-tumour doses when either parallel
opposed fields were used or when gross disease was
treated with single lateral fields. Stated doses are surface
doses or depth dose at 1 cm when single en face fields
were used for microscopic disease.
In general, dogs suffering from a macroscopic tumour not
amenable for surgery were given coarsely fractionated RT
with a palliative intent. Dogs with microscopic residual
disease after tumour surgery and a good prognosis were
given standard (fine) fractionated therapy with curative
intent. Acute radiation toxicity was assessed by the clini-
cian using the VRTOG scoring scheme [13] (additional
file 1).
Medication
Prednisone, famotidine or chemotherapy was used in
conjunction with RT in a few cases because of the biologic
behavior of the specific tumour. All side effects were
treated symptomatically when they occurred. Antibiotics,
non steroidal anti inflammatory drugs, prednisone and
occasionally butorphanol sublingual tablets were pre-
scribed when needed. Some of the dogs that had grade 3
cutaneous reactions [13] were managed with hydrogel
(Intrasite, Smith-Nephew) and a moisture vapor permea-
ble dressing (Allevyn, Smith-Nephew) during their maxi-
mal phase of acute toxicity.
Questionnaire design
A questionnaire was developed to explore owner's percep-
tions and experiences from having their dog treated with
RT for malignancy (tables 1a, b, and 2, translation from
the Swedish original). The questionnaire was pre-tested
by a few veterinarians and after minor changes also by 3
owners who had their dog treated with chemotherapy.Acta Veterinaria Scandinavica 2009, 51:19 http://www.actavetscand.com/content/51/1/19
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Table 1: a Responses to the owner questionnaire, categorical answers.
Question Category Number %
1) Opinions on the dog and family members related to radiation treatment (RT).
How did I learn about RT as an available treatment option for my dog Advice of my primary vet 20 87
Second opinion of another veterinarian 2 9
Trough media/internet 1 4
I had previous knowledge about RT in humans Yes 9 39
No 14 61
How did I decide to use RT for my dog? My own decision 6 26
Consensus of family members in favor 17 74
Family disagreed 0 0
My dog had veterinary care insurance that covered most of the cost for RT Yes 9 39
No 14 61
2a) Describe your impression of the well-being of your dog during the weeks while RT was performed
My dog appeared well during the time of treatment Yes, very well 15 65
Yes, fairly well 8 35
Did not appear well 0 0
My dog found it unpleasant to visit the hospital Yes 3 13
Yes a little 11 48
No 9 39
My dog appeared tired during the treatment Yes 5 22
Yes a little 6 26
Not tired 12 52
Did I notice a change in the dog's quality of life? No Impact 19 83
Positive impact 3 13
Negative impact 1 4
2b) Describe what happened during the 4 weeks following completion of RT. (This is when acute skin and/or mucosal effects 
occur and heal).
My dog appeared well during these weeks Yes, very well 14 61
Yes, well 6 26
No, not well 3 13
My dog experienced discomfort in the radiation field Yes severe 5 22
Yes, minor 10 44
No discomfort seen 8 35
My dog was in pain during these Weeks Yes, severe 3 13
Yes, modest 6 26
No 14 61
My dog experienced side effects Yes, severe 5 22
Yes, minor 10 44
No 8 35
During post treatment, did the quality of life of the dog seem different? No impact 15 65
Positive impact 5 22
Negative impact 3 13
b Responses to owner questionnaire, categorical answers.
Question Category Number %
3) Describe your own perception or personal experience from when your dog had RT:
I believe that RT cured my dog's cancer Yes 9 39
No 11 48
Can't decide 2 9
I believe that RT does prolong life until tumour related discomfort occur Yes 21 91
No 2 9
My dog's clinical signs disappeared because of RT: 
(limited to 14 dogs with gross disease)
Yes, completely (n = 14) 5 36
Yes, in part (n = 14) 4 29
No (n = 14) 5 36
NAa (subclinical disease) (n = 23) 9 39
I believe I was adequately informed about the RT before starting RT Yes 22 96
No 1 4Acta Veterinaria Scandinavica 2009, 51:19 http://www.actavetscand.com/content/51/1/19
Page 4 of 10
(page number not for citation purposes)
Based on their comments the questionnaire was slightly
modified. The final version included a total of 31 closed
questions (tables 1a and 1b) and, at 3 locations requests
for further comments. In another 8 questions, owners
were asked to grade their answers (writing a number from
0 to 10) with endpoints defined as in table 2. It was the
subjective perception of the owner that was being targeted
throughout the questionnaire.
The questionnaire consisted of four sections (tables 1a, b
and 2). The purpose of the first section was to cover the
background, obtaining information about how the owner
was informed that RT was a possible option, the composi-
tion of the household of the dog at the time and how the
decision to have the dog undergo RT was made. The sec-
ond (dog) section investigated the experiences of the dog
and its quality of life during RT and for the first month
thereafter. The third (owner) section explored how the
owners felt about having their dog treated with RT,
whether therapy was beneficial and reactions from other
people who learned the dog had received RT. The final
section evaluated owner satisfaction with the outcome, if
it was worth the effort required and if they would make
the same decision again if a similar situation occurred
with another dog. Owners were also asked to evaluate the
importance of various factors on that decision (table 2)
The printed questionnaire was mailed together with an
explanatory covering letter to all owners during October
2007. It was completed during a telephone interview
(author NÅD) during November 2007.
A short questionnaire was constructed to explore the atti-
tudes towards use of RT among a convenience sample of
Swedish veterinarians. The following questions were asked
to define the veterinarian's knowledge of RT: time since
graduation, present occupation and whether he/she had
attended lectures on small animal clinical oncology and/or
small animal RT. The respondents were asked to grade their
opinions on 4 different issues using a number from 0 to 10.
The issues were if small animal RT is justified, what is the
well-being of the dog during RT, if RT is a hazard for per-
sonnel and how often RT is indicated in a clinical setting. In
three of the questions, 10 was defined as the most positive
rating but in the question concerning potential risk for per-
sonnel, 10 was defined as the most severe risk. Voluntary
additional comments were encouraged. Veterinarians
attending three professional meetings (a course on cytology
for practitioners, a congress of Swedish dermatologists and
a seminar on the ethics of canine oncology) in Sweden were
invited to participate, anonymously. Eighty-two question-
naires were distributed.
Data analysis
Results of the owner survey are presented using medians,
ranges, means and standard deviations, for continuous
and score variables. The qualitative variables are presented
using numbers and percentages.
The information was consistent with the outcome for the dog Yes 21 91
No 2 9
The information agreed with what I experienced Yes 22 96
No 1 4
My dog experienced more severe side effects than I expected Yes 5 22
No 18 78
My dog experienced fewer side effects than I expected Yes 14 61
No 9 39
I was well informed how to care for side effects Yes 19 83
No 0 0
NA 4 17
Management of side effects was effective Yes 10 43
Yes in part 5 22
No 0 0
NA 8 35
4) Describe the level of satisfaction with RT in your dog.
RT was worth my commitment in time, travel, caring for the dog at home etc. Yes 23 100
No 0 0
Subjecting my dog to RT was worth my financial cost Yes 22 96
No 1 4
I consider that the discomfort to my dog due to RT was worth the gain Yes 23 100
No 0 0
I would use RT again in a similar situation with another dog. Yes 22 96
No 0 0
Missing 1 4
a NA- not applicable
Table 1: a Responses to the owner questionnaire, categorical answers. (Continued)Acta Veterinaria Scandinavica 2009, 51:19 http://www.actavetscand.com/content/51/1/19
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Results of the veterinarian questionnaire are presented as
median, ranges and means. Respondents were categorized
into two groups based on their stated knowledge of RT;
one category that responded that they had not attended
lectures in small animal oncology or clinical RT con-
trasted to those that had attended lectures in at least one
of the subjects. The scores from the four questions were
compared using the Wilcoxon signed test. The two-sided
p-value limit was set < 0.05.
Results
Animals
Of the 23 dogs, 4 had died or been euthanized when the
interview was conducted. At the time of treatment the
median age was 8 years (range 2–13). Gender distribution
was 8 intact females, 13 intact males, 1 spayed female and
1 castrated male. Breeds included 3 golden retrievers, 2
Labrador retrievers, 2 miniature schnauzers and one of
each the following breeds: flatcoated retriever, Bernese
mountain dog, Swedish elkhound, rottweiler, whippet,
bearded collie, wirehaired dachshound, boxer, Airdale ter-
rier, German shepherd, Shetland sheepdog, Danish-Swed-
ish farm dog.
Twelve dogs had undergone incomplete tumour resection
prior to referral and 3 of these suffered from gross progres-
sive disease. Information on histological diagnoses, total
doses of radiation and type of fractionation are summa-
rized in table 3.
Radiation therapy
A single field was used in 18 cases and parallel-opposed
fields in 5 cases. Four dogs received 16–18 fractions of 3–
3.5 Gy delivered 4 days a week over a period of 25 days for
Table 2: Responses to the owner questionnaire, ordinal and continuous answers.
Number of owners with a response
Q u e s t i o n M e a n S T D M e d i a n M i n M a x01234567891 0
1b. How many people were 
there in the household?
2 . 61 . 2 216---------- -
How many dogs were there in the 
household?
1.7 0.7 2 1 3
How many cats were there in the 
household?
0.7 1.2 0 0 4
2b. My overall impression how RT was experienced by my dog 
(quality of life), from initiating RT until side effects had declined.
0 = good quality- 10 = severe negative impact on dog
2 . 92 . 4 20 84364021210 0
3b. Reactions from acquaint-
ances when informed that my 
dog had undergone RT for can-
cer.
Percent 0 10 20 30 40 50 60 70 80 90 100
P o s i t i v e  r e a c t i o n s  % 7 6 . 9 2 9 . 5 9 00 1 0 01020020424 8
N e g a t i v e  r e a c t i o n s  % 1 4 . 3 1 9 . 8 1 00 8 0 1 0542010010 0
N e u t r a l  o r  N o  r e a c t i o n  % 1 1 . 8 2 6 . 8 00 1 0 0 1 8200011000 1
0 = Calm, confident – 10 = Very stressful and inconvenient
Overall: My own experience from
start of RT until side effects declined
2 . 31 . 9 20 65372141000 0
4b. Would I choose RT again in a 
similar situation?
Grade the importance of following
factors deciding to treat with RT or
not
0 = no importance, negligible- 10 = crucial influence, very important.
My financial costa 2 . 22 . 6 10 89321230020 0
Prognosis: chance for curea 7 . 33 . 1 80 1 02000140232 8
Prognosis: chance for longer life
without tumour related discomforta
9 . 51 . 1 1 06 1 00000 011121 7
Severity of expected side effectsa 6 . 62 . 4 71 1 00102052432 3
Number of treatments requireda 3 . 02 . 8 20 1 06152141100 1
M y  i n v e s t m e n t  i n  t i m e  a n d  t r a v e l 2 . 32 . 7 20 1 09142031100 1
a one response missing, b for titles of sections 1–4, see tables 1a and 1bActa Veterinaria Scandinavica 2009, 51:19 http://www.actavetscand.com/content/51/1/19
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postoperative microscopic disease, resulting in total doses
from 48 to 54 Gy. One dog received, after cytoreductive
surgery, 12 fractions of 4 Gy 3 days a week over a period
of 25 days, for residual macroscopic tumour.
For 18 dogs, coarse fraction schemes were used, adminis-
trating 3 fractions of 8–10 Gy on a day 0-7-21 schedule (5
dogs), 4 weekly fractions of 8 Gy (4 dogs) or 5–6 fractions
of 5–6 Gy 1–2 times a week (9 dogs) resulting in total
doses from 24 to 36 Gy. Of these 18 dogs, 12 dogs
received RT with a palliative intent for advanced local dis-
ease not amenable to surgery and in one dog as pain man-
agement for appendicular osteosarcoma.
One dog suffered from localized mucosis fungoides and
the remaining four dogs were treated with coarsely frac-
tionated therapy for postoperative microscopic disease
instead of regular fractionation because of other consider-
ations (high probability of metastatic dissemination, the
owner considered the dog too old or because coarse frac-
tionation techniques have been reported superior for the
actual diagnosis (Oral malignant melanoma: [14-16])).
All but 3 dogs were brought to the hospital for RT on treat-
ment days. Of the 3 dogs that were hospitalized, two dogs
stayed at home during weekends.
Medication
One dog with pharyngeal oral malignant melanoma had
the primary tumour removed prior to RT and also received
carboplatin (300 mg/m2 and 270 mg/m2 respectively, as
intravenous infusions during 5–10 minutes) in conjunc-
tion with the second and sixth fraction of RT. This dog
developed myelo-suppression as a result of chemotherapy
and this fact impacted its quality of life. The two dogs that
had macroscopic mast cell tumours were medicated with
prednisone and famotidine 1–2 weeks prior to initiation
of RT, during, and 1 month after RT.
Radiation Toxicity
Grading of acute radiation morbidity, according to the
VROTG scheme [13] (additional file 1), assessed by the
clinician, revealed moderate toxicity with mean and
median scores of 1.6 and 1. These average scores included
6 dogs with grade 3 toxicity in which confluent moist der-
matitis was present (table 3).
If separated into regular fractionation treatment and
coarse fraction treatment, the average toxicity score was
1.4 for regular fraction compared to 1.5 in the coarse frac-
tion group.
Two of the dogs with grade 3 toxicity had received coarse
fraction treatment for a tumour for which the symptoms
were hard to distinguish from those of radiation toxicity
since the original lesion was moist and irritated (sweat
gland adenocacinoma, cutaneous angiomatosis). Another
dog in the coarse fraction group with grade 3 toxicity had
extensive self-inflicted trauma by licking prior to assess-
ment of toxicity.
Dog owners' questionnaire
All 23 owners responded, all questionnaires but one were
complete and the results are shown in tables 1a, b and 2.
The time span from completion of RT until the interview
Table 3: Diagnosis and type of radiotherapy (RT) in the 23 dogs in the study: Radiation toxicity score and number of dogs dead at 
interview are also shown.
Diagnosis Site Standard fractionation RTa
No. of dogs (scoreb)
Coarse fractionation RTc
No. of dogs (scoreb)
Mast cell tumour
all grades
Extremities (n = 2)
Head (n = 3)
2 (1,1) 3 (1*, 1, 2)
Oral malignant melanoma Cheek (n = 1) Pharynx (n = 1) 1 (1*)
1 (0)
Mucosis fungoides Head 1 (0)
Hemangiopericytoma Extremities 2 (1,3) 2 (2, 3)
Fibrosarcoma Maxilla 1 (1)
Undifferentiated sarcoma Axilla 1 (0*)
Chondrosarcoma Maxilla 1 (3)
Osteosarcoma Appendicular 1 (3)
Cutaneous angiomatosis Metatarsus 2 (1, 3)
Sweat gland carcinoma Extremities 2 (2, 3*)
Adenocarcinoma Nasal cavity 1 (0)
Squamous cell carcinoma Nasal cavity 1 (2)
Thyroid carcinoma Ventral neck 1 (0)
a RT in 3–4 Gy fractions, total dose 48–54 Gy.
b VROTG radiation morbidity score (see additional file 1, LaDue T, Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. 
Veterinary Radiology & Ultrasound 2001;42:475–476).
c RT in 5–10 Gy fractions, total dose 24–36 Gy.
* Dead or euthanized at the time of interview.Acta Veterinaria Scandinavica 2009, 51:19 http://www.actavetscand.com/content/51/1/19
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varied from 1 to 19 months (data not shown). All owners
thought that their dog appeared well during RT, even
though they noticed some tiredness or nervousness. Dur-
ing the first 4 weeks after completion of RT, when acute
radiation dermatitis typically culminates and then heals,
13% of owners considered that their dog had pain that
negatively impacted quality of life. A positive influence of
RT on quality of life was reported by 22% since the palli-
ative treatment had diminished existing inconvenience
from the tumour. The overall impression of how RT was
experienced by the dog, was rated 2 (median) on a scale
(0–10) where 0 was defined as the best quality of life
(table 2). Owners were satisfied with the information
given before and during RT and felt that the outcome was
well-correlated to their expectations. For example, the
median rating of the owners' overall experience from ini-
tiating RT until side effects declined was 2 (0 equals calm
and confident and 10 very stressful (table 2)).
Owners were not disturbed by efforts required of them
and all owners, except one, would make the same decision
about RT again if a similar situation occurred (tables 1b
and 2). The most essential factor for this decision was the
chance to prolong the duration of freedom from disturb-
ing tumour-related clinical signs. The chance for cure was
of less weight but still important, followed by the extent
of expected side effects. The commitment of time and
effort and cost had low impact among these owners (table
2). The voluntary additional comments were sparse but
positive. It was often stated that this care had been better
and more compassionate compared to human healthcare.
Questionnaire to veterinarians
Sixty-seven of the 82 questionnaires (81.7%) distributed
to veterinarians were returned. Of the responding veteri-
narians, 20 had not attended education programs on vet-
erinary oncology or RT, whereas 47 had studied one or
both of the subjects. The scores of positive attitude
towards RT were lower (p = 0.01) in the less-informed
group with a median score of 5 (range 0–10, mean 4.5)
compared to the median 7.5 (range 1–10, mean 6.9)
among those who had sought more information on can-
cer therapy. Assumptions about the quality of life of dogs
treated with RT (where 0 equals bad and 10 equals good)
was also different (p = 0.003) between the two groups
with a median score of 6 (range 2–10, mean 6.5) in the
better-informed group, compared to 5 (range 0–8, mean
4.6) among those who had not attended the mentioned
lectures. With regard to whether RT is a hazard to person-
nel, there was no significant difference between the
groups (p = 0.37) with a median of 5 for both. (Mean
score for assumptions of danger (0 equals no hazard, 10
equals severe danger) was 4.5 (range 0–10) in the less-
educated group compared to 3.6 (range 0–8) in the
other.) Clinical indications for RT were considered to
occur slightly more often (p = 0.03) by the informed vet-
erinarians with a median of 5 (range 0–9, mean 5.4) com-
pared to the less-informed group, median 5 (range 0–7,
mean 4.2) (0 equals never indicated).
Discussion
It was encouraging to a veterinarian pioneering the use of
RT in Sweden, that these owners, that choose to have RT
performed on their dogs, believed RT had been a worth-
while treatment modality and that the discomfort for the
dog seemed manageable and acceptable in relation to the
health benefits. All owners found RT worth the efforts
required of them and all but one would make the same
decision again. (The only exception was an owner that did
not respond because she was too old to have another dog
in her lifetime). However, these respondents were not a
random sample of Swedish animal owners with dogs suit-
able for RT, but a biased group that had decided to use RT
on their dogs. They took this decision in spite of cost,
travel and other inconveniences. Nevertheless, if the expe-
rience had been very negative, they presumably would
have expressed that on the questionnaire. A survey of
reluctant owners that actually declined RT may have given
different results and reasons why they choose not to use
RT.
Most owners perceived their dog's quality of life to be
unaffected or improved during the weeks of RT. One dog
that deteriorated also had carboplatin infusions and suf-
fered from myelo-suppression which undoubtedly con-
tributed to the reduced quality of life. The majority of
owners also thought that the acute side effects were well-
tolerated by their dog. Every owner stated that the incon-
venience for the dog was acceptable in relation to the gain.
The time span from completing RT until the interview was
performed was long for some owners and this may have
affected the owner response, provided the impression of
various experiences may change with time. Also, if owners
had an unstated bad conscience for putting their dog
through painful side effects, they may have repressed their
true perceptions and recalled a false positive experience.
However, in general, the clinicians' assessments of mor-
bidity correlated with owner impressions (data not
shown). The average score of acute side effects [13] in the
studied group was modest, likely reflecting the high per-
centage of cases receiving a palliative regimen. The confus-
ing fact that average and median scores of radiation
toxicity were higher in the coarse fraction group (1.5
and1.5) compared to the regular fraction group (1.4 and
1) may be a function of difficulties in assessing toxicity
when the original lesion was moist and irritated. If these
2 cases and also the self-inflicted trauma case were
excluded from the group of animals that received coarse
fraction treatment, average and median scores (1.2 and 1)
would be closer to the expected outcome. Small sampleActa Veterinaria Scandinavica 2009, 51:19 http://www.actavetscand.com/content/51/1/19
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size also gives these uncommon cases high impact on the
outcome.
Few dogs were subjected to RT because of microscopic dis-
ease (4 dogs that received standard fractionation, 3 dogs
that received coarse fractionation). The indications for
curative intent RT may have been less well known during
these initial 19 months with access to RT in Sweden. Thus
most referred cases were advanced and not amenable for
surgery.
There are limitations with this study. The sample size was
small and the patient material was heterogeneous with
different diagnoses, locations and other considerations
leading to different total doses, used kV, field sizes, frac-
tion sizes, intervals between fractions and medications
among the animals. This prohibits the data from being
used as an evaluation of treatment efficacy or whether the
dogs had more side effects than was acceptable in correla-
tion with outcome (a difficult task with a short follow-
up). However, the aim of this study was to seek the owner
perspective in the available group of clients.
The telephone interviews were conducted by the clinician
in charge (NÅD) of the performed RT. There may be a loy-
alty-based relationship between this clinician and the
owner although owners were repeatedly encouraged to be
totally honest in their responses. This design may have
produced bias in form of "too positive" responses. On the
other hand, this intimate setting may have facilitated
retrieval of specific information and also may have con-
tributed to the 100% response rate among owners. Using
telephone interviews was to be one way of preventing mis-
understandings on both sides.
A rough attempt was made to make a judgment of the
dogs' quality of life through a few owner questions. In
contrast, there are in human cancer care questionnaires
such as the "European Organization for Research and
Treatment of Cancer 30-item core quality of life question-
naire" (EORTC QLQ-30), a validated, standardized and
copyrighted instrument that is used in more than 3000
studies worldwide [17,18]. It is supplemented by disease
specific modules e.g. breast, lung, head and neck cancer.
These are used to assess the influence of side effects on
quality of life among groups of patients with specific diag-
noses. However, assessments are subjective also from
standardized and validated questionnaires, since the
information relies on self-reported data [19]. The EORTC
QLQ-30 should be used to retrieve information only on
subjective side effects and more quantitative evaluation
should be used for objective changes. One cannot con-
clude from one to the other since patient assessments of
symptoms have been shown to be poor predictors of
objective findings [19,20]. In veterinary medicine, it has
been shown that few dog-owners were able to distinguish
the various grades of lameness in cases of cranial cruciate
ligament rupture and repair. An inconsistency was found
between owner perception of lameness and results of
force plate analysis performed on dogs that underwent
surgery for this problem. However, owner assessment was
concluded useful for estimating functional outcome of
cruciate repair, but should not replace professional judg-
ment [21,22].
The overall value of owner opinion surveys can be ques-
tioned. The issue whether another person (proxy) other
than the patient, is able to judge quality of life for the
patient has been investigated in several human studies
[23-25]. When patient, spouse and treating physician
completed the same quality of life questionnaire, there
was substantial variability between ratings of quality of
life by physicians or partners, as compared to patient rat-
ings [23]. In a similar triple survey concerning patients
that had undergone anterior skull base surgery, the oper-
ating surgeon ratings had no correlation with patient rat-
ings, with surgeons overestimating patients' quality of life
while there was a significant overall agreement between
patient and partner responses [24]. In children too young
or too severely ill to answer a questionnaire, parent proxy-
reports may be the only available information. Several
reports of inconsistent proxy-report between parent and
pediatric patient have been presented [25-27] but statisti-
cal strategies to examine proxy agreement in quality of life
have not reached consistency [25].
Owners' statements about their pet are also subjective
proxy-reports. There may be misjudgments on pain or dis-
comfort. However, when overall quality of life during a
defined time span is evaluated, the owner is the one who
spends most of their time with the pet and knows the hab-
its of their dog. Owners' proxy assessments complement
the professional evaluation made by veterinary surgeons,
when a true estimation of quality of life is the goal.
The questionnaire to veterinarians was limited to volun-
teers, clearly being a convenience sample. The attendees at
the 3 meetings were not representative of Swedish small
animal veterinarians in general. However, interestingly
significant differences were found in 3 of 4 questions
posed. Veterinarians that had attended education on clin-
ical oncology or small animal RT had more positive atti-
tudes than those less well-informed. This could indicate a
pre-existing skepticism until evidence-based information
is gained. The result could also be interpreted that these
negative veterinarians had made active decisions not to
become informed because of a pre-existing standpoint
that RT for animals is unethical, as some of them com-
mented in the questionnaire. The veterinarians assump-
tions of quality of life of dogs submitted to RT were
investigated: with 0 being the best quality of life, owners
score was rated 2 (median) compared to score of 4 and 5Acta Veterinaria Scandinavica 2009, 51:19 http://www.actavetscand.com/content/51/1/19
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(median) among informed and less-informed veterinari-
ans respectively. Thus according to the owners, well-being
of the dog submitted to RT was clearly more positive than
these veterinarians thought it would be.
Among both categories of surveyed veterinarians, the per-
ception of RT as a hazard was common. Personnel are
never allowed to be in the treatment room during RT, and
the walls of this room have to be in accordance with the
legislation. Thus, when correctly performed, RT actually
subjects health care workers to less radiation than ordi-
nary X-ray imaging techniques, where people may get
exposed to radiation, while holding the animals. Volun-
tary comments from responding veterinarians also indi-
cated confusions between RT and chemotherapy and
between external beam RT and systemic radio-nucleotide
therapy or brachy-therapy. Thus some individuals seemed
to believe that the patient becomes radioactive from exter-
nal beam RT, or is shedding cytotoxic waste.
Availability of RT brings new possibilities of curing an
unknown number of dog and cat patients and to relieve
clinical signs from cancer in other animals, given that RT
is considered early in the workup of oncology cases. For
this to happen, awareness among veterinary practitioners
about the main indications and limitations of RT is man-
datory. Evaluation of owner experience from performed
RT may, especially when the procedure is newly intro-
duced (e.g. in a country), together with the numerous
available scientific reports of efficacy and morbidity, assist
owners and veterinary surgeons in the decision-making
process in case of malignancy.
The goal of small animal veterinary decisions (not just
oncological) should be that the dog can benefit from a
good quality of life. To assess outcome, veterinarians will
have to continue to rely on owner proxy-reports, together
with more objective clinical assessments. Therefore the
development of standardized and validated instruments
for rating the quality of life of the animal is a field that
deserves continuing interest.
Conclusion
The owners of the first group of dogs treated with RT in
Sweden, considered RT as a worthwhile treatment modal-
ity and that the discomfort for the dog seemed managea-
ble and appropriate relative to the benefits. The findings
from the small survey of veterinarians suggest that increas-
ing the information about small animal RT and cancer
therapy will improve veterinary attitudes about use of RT
and other therapies.
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